Seven ways TRIPs is enhanced for pharmaceutical companies

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Seven ways TRIPs is enhanced for pharmaceutical companies

Many free trade deals go beyond the provisions of the WTO’s TRIPs Agreement. Here are some of the obligations parties often sign up to that particularly affect pharmaceutical companies

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login
more from across site and SHARED ros bottom lb

More from across our site

Tarun Gandhi joins us for our ‘Five minutes with’ series to discuss the biggest misconception about IP, the importance of staying curious, and his biggest inspiration
It’s that time of the year for law firms to participate in the research for the Managing IP Awards and IP STARS rankings
Latham & Watkins client CoStar filed an opposition brief against Crexi, arguing that their motion to stay is a distraction from an imminent copyright trial
News of Ultrahuman suing Oura in India and Apple accusing Oppo of trade secret theft were also among the top talking points
The firm has added six practitioners in recent weeks as it takes measured steps to build its IP practice with a focus on trade secrets work
Partners at law firm Silva reveal how their recent geographical indication win in India for Chilean Pisco paves the way for future victories internationally
Lawyers at Finnegan unpick the UK government’s SEP consultation, and offer tips for patent litigators
In major recent developments, a request for automatic service to counsel in provisional proceedings was rejected and a PI covering Spain was granted
Julia Ericsson of Sandart in Sweden discusses litigating patents at the UPC, overcoming prejudice and how to encourage associates to develop their careers in IP
Reed Smith lawyers say that with the UK’s AI law in a state of flux, IP owners should look beyond the country's borders
Gift this article